nach oben

Erschienen in:

14.08.2019 | Original articles

Effect of new oral anticoagulants on platelet indices in non-valvular atrial fibrillation patients

verfasst von: Irfan Veysel Duzen, Elif Oguz, Yusuf Cekici, Fethi Yavuz, Ertan Vuruskan, Isa Sincer, Fatih Poyraz, Hayri Alıcı, Umit Yuksek, Abdullah Orhan Demirtas, Murat Sucu

Erschienen in: Herz | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

New-generation oral anticoagulants (NOACs) are now preferred as a first-line treatment in the management of atrial fibrillation for prevention of thromboembolic complications. Mean platelet volume (MPV), one of the indicators of increased platelet activity, is also associated with an increased stroke risk in atrial fibrillation patients. The aim of this study was to evaluate changes in MPV, platelet distribution width (PDW) and plateletcrit following use of NOACs. The study included 116 patients with non-valvular atrial fibrillation without previous NOAC use. Complete blood counts, biochemical analyses and echocardiography were performed for all patients. No significant differences were observed in MPV or other platelet indices at 6 months compared to baseline. Our results indicate that MPV and other platelet indices are not affected by NOAC use in non-valvular atrial fibrillation patients.

Pistoia F, Sacco S, Tiseo C, Degan D, Ornello R, Carolei A (2016) The epidemiology of atrial fibrillation and stroke. Cardiol Clin 34(2):255–268PubMedCrossRef

Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT et al (2015) 7.50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study a cohort stud. Lancet 386(9989):154–162PubMedPubMedCentralCrossRef

Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988PubMedCrossRef

Diener HC, Hart RG, Koudstaal PJ, Lane DA, Lip GYH (2019) Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week. J Am Coll Cardiol 73(5):612–619PubMedCrossRef

Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955–962PubMedCrossRef

Rienstra M, Damman K, Mulder BA, Van Gelder IC, McMurray JJ, Van Veldhuisen DJ (2013) Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis. JACC Heart Fail 1(1):21–28PubMedCrossRef

Camm AJ, Breithardt G, Crijns H, Dorian P, Kowey P, Le Heuzey JY, Merioua I, Pedrazzini L, Prystowsky EN, Schwartz PJ et al (2011) Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol 58(5):493–501PubMedCrossRef

Wagner DD, Burger PC (2003) Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 23(12):2131–2137PubMedCrossRef

Fateh-Moghadam S, Htun P, Tomandl B, Sander D, Stellos K, Geisler T, Langer H, Walton K, Handschu R, Garlichs C et al (2007) Hyperresponsiveness of platelets in ischemic stroke. Thromb Haemost 97(6):974–978PubMedCrossRef

10.

Bath PM, Butterworth RJ (1996) Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 7(2):157–161PubMedCrossRef

11.

Han JY, Choi DH, Choi SW, Kim BB, Ki YJ, Chung JW, Koh YY, Chang KS, Hong SP et al (2013) Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus. Platelets 24(5):401–406PubMedCrossRef

12.

Tekin G, Tekin YK, Sivri N, Yetkin E (2013) Mean platelet volume in patients with nonvalvular atrial fibrillation. Blood Coagul Fibrinolysis 24(5):537–539PubMedCrossRef

13.

Shilpi K, Potekar RM (2018) A study of platelet indices in type 2 diabetes mellitus patients. Indian J Hematol Blood Transfus 34(1):115–120PubMedCrossRef

14.

Gang L, Yanyan Z, Zhongwei Z, Juan D (2017) Association between mean platelet volume and hypertension incidence. Hypertens Res 40(8):779–784PubMedCrossRef

15.

Icli A, Aksoy F, Nar G, Kaymaz H, Alpay MF, Nar R, Guclu A, Arslan A, Dogan A (2016) Increased mean platelet volume in familial cypercholesterolemia. Angiology 67(2):146–150PubMedCrossRef

16.

Nadar S, Blann AD, Lip GY (2004) Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med 36(7):552–557PubMedCrossRef

17.

Erhart S, Beer JH, Reinhart WH (1999) Influence of aspirin on platelet count and volume in humans. Acta Haematol 101(3):140–144PubMedCrossRef

18.

Gu X, Fu X, Wang Y, Zhang W, Fan W, Jiang Y, Hao G, Miao Q, Li Y, Zhi W (2017) Comparison of ticagrelor and high-dose clopidogrel on the platelet functions in patients with inadequate response to clopidogrel. Am J Cardiovasc Dis 7(1):1–8 (eCollection 2017)PubMedPubMedCentral

19.

Jagroop IA, Mikhailidis DP (2000) Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. J Hum Hypertens 14(9):581–585PubMedCrossRef

20.

Bath P, Algert C, Chapman N, Neal B (2004) PROGRESS Collaborative Group Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 35(3):622–626PubMedCrossRef

21.

Gungoren F, Besli F, Caliskan S, Polat U, Basar C, Serdar OA (2016) Statin therapy may not effect NLR and MPV levels in patients with hypercholesterolemia: a retrospective study. Angiology 67(6):536–540PubMedCrossRef

22.

Akyüz A, Akkoyun DÇ, Değirmenci H, Oran M (2016) Rosuvastatin decreases mean platelet volume in patients with diabetes mellitus. Angiology 67(2):116–120PubMedCrossRef

23.

Arık OZ, Ozkan B, Kutlu R, Karal H, Sahin DY, Kaypaklı O, Ozel D, Cayli M (2014) Relationship between platelet indices and international normalized ratio in patients with non-valvular atrial fibrillation. Platelets 25(5):311–316PubMedCrossRef

24.

Pizzulli L, Yang A, Martin JF, Lüderitz B (1998) Changes in platelet size and count in unstable angina compared to stable angina or non-cardiacchest pain. Eur Heart J 19(1):80–84PubMedCrossRef

25.

Lai HM, Xu R, Yang YN, Ma YT, Li XM, Zhao Q, Chen QJ, Zhai H, Liu F, Chen BD (2015) Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv 85(Suppl 1):724–733PubMedCrossRef

26.

Taglieri N, Saia F, Rapezzi C, Marrozzini C, Bacchi Reggiani ML, Palmerini T, Ortolani P, Melandri G, Rosmini S, Cinti L et al (2011) Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. Thromb Haemost 106(1):132–140PubMed

27.

Higaki T, Kurisu S, Watanabe N, Ikenaga H, Shimonaga T, Iwasaki T, Mitsuba N, Ishibashi K, Dohi Y, Fukuda Y et al (2016) Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention. Heart Vessels 31(3):269–274PubMedCrossRef

28.

Verdoia M, Pergolini P, Rolla R, Nardin M, Barbieri L, Schaffer A, Bellomo G, Marino P, Suryapranata H, De Luca G (2015) Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Expert Opin Pharmacother 16(12):1739–1747PubMedCrossRef

29.

Yang A, Pizzulli L, Lüderitz B (2006) Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res 117(4):371–377PubMedCrossRef

30.

Colkesen Y, Acil T, Abayli B, Yigit F, Katircibasi T, Kocum T, Demircan S, Sezgin A, Ozin B, Muderrisoglu H (2008) Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation? Blood Coagul Fibrinolysis 19(5):411–414 (Jul)PubMedCrossRef

31.

Bayar N, Arslan S, Cagirci G, Ureyen CM, Cay S, Yuksel IO, Koklu E, Erkal Z, Kucukseymen S (2015) Usefulness of mean platelet volume for predicting stroke risk in paroxysmal atrial fibrillation patients. Blood Coagul Fibrinolysis 26(6):669–672PubMedCrossRef

32.

Ha SI, Choi DH, Ki YJ, Yang JS, Park G, Chung JW, Koh YY, Chang KS, Hong SP (2011) Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets 22(6):408–414PubMedCrossRef

33.

Choi SW, Kim BB, Choi DH (2017) Stroke or left atrial thrombus prediction using antithrombin III and mean platelet volume in patients with nonvalvular atrial fibrillation. Clin Cardiol 40(11):1013–1019PubMedPubMedCentralCrossRef

34.

Han JY, Choi DH, Choi SW, Kim BB, Ki YJ, Chung JW, Koh YY, Chang KS, Hong SP (2013) Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus. Platelets 24(5):401–406PubMedCrossRef

35.

Wan JL, Ma ZW (2017) Value of Mean Platelet Volume for Prognosis of Patients with Acute Cerebral Infarction. Clin Lab 63(11):1801–1807PubMed

36.

Gul SS, Gozke E (2018) Mean platelet volume in patients with acute ischemic stroke with nonvalvular atrial fibrillation. Clin Lab. https://doi.org/10.7754/clin.lab.2018.180543CrossRefPubMed

37.

Yılmaz F, Köklü E, Kizilirmak Yilmaz F, Sarıönder Gencer E, Alparslan AŞ, Yıldırımtürk Ö (2017) Evaluation of mean platelet volume and platelet distribution width in patients with asymptomaticintermediate carotid artery plaque. Kardiol Pol 75(1):35–41PubMed

38.

Providência R, Faustino A, Paiva L, Fernandes A, Barra S, Pimenta J, Trigo J, Botelho A, Leitão-Marques AM (2013) Mean platelet volume is associated with the presence of left atrial stasis in patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord 13:40PubMedPubMedCentralCrossRef

39.

Choudhury A, Chung I, Blann AD, Lip GY (2007) Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of “healthy control subjects” and “disease control subjects” in sinus rhythm. J Am Coll Cardiol 49(19):1957PubMedCrossRef

40.

Thompson CB, Love DG, Quinn PG, Valeri CR (1983) Platelet size does not correlate with platelet age. Blood 62(2):487–494PubMedCrossRef

41.

Pathansali R, Smith N, Bath P (2001) Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia. Platelets 12(5):292–297PubMedCrossRef

42.

Gladwin AM, Martin JF (1990) The control of megakaryocyte ploidy and platelet production: biology and pathology. Int J Cell Cloning 8(4):291–298PubMedCrossRef

43.

Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I (2010) Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia 14(1):28–32PubMedPubMedCentral

44.

Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK (2006) Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 59(2):146–149PubMedPubMedCentralCrossRef

45.

Mohr R, Martinowitz U, Golan M, Ayala L, Goor DA, Ramot B (1986) Platelet size and mass as an indicator for platelet transfusion after cardiopulmonary bypass. Circulation 74(5 Pt 2):153–158

46.

Akpinar I, Sayin MR, Gursoy YC, Aktop Z, Karabag T, Kucuk E, Sen N, Aydin M, Kiran S, Buyukuysal MC et al (2014) Plateletcrit and red cell distribution width are independent predictors of the slow coronary flow phenomenon. J Cardiol 63:112–118PubMedCrossRef

47.

Akpek M, Kaya MG, Yarlioglues M et al (2011) Relationship between platelet indices and spontaneous echo contrast in patients with mitral stenosis. Eur J Echocardiogr 12:865–870PubMedCrossRef

48.

Akpinar I, Sayin MR, Gursoy YC, Karabag T, Kucuk E, Buyukuysal MC, Aydin M, Haznedaroglu IC (2013) Plateletcrit: A platelet marker associated with saphenous vein graft disease. Herz. https://doi.org/10.1007/s00059-013-3798-yCrossRefPubMed

49.

Uğur M, Ayhan E, Bozbay M, Çiçek G, Ergelen M, Işık T, Uyarel H, Ertaş G, Çakıllı Y, Öz A et al (2014) The independent association of plateletcrit with long-term outcomes in patients undergoing primary percutaneous coronary intervention. J Crit Care 29:978–981PubMedCrossRef

Titel: Effect of new oral anticoagulants on platelet indices in non-valvular atrial fibrillation patients
verfasst von: Irfan Veysel Duzen
Elif Oguz
Yusuf Cekici
Fethi Yavuz
Ertan Vuruskan
Isa Sincer
Fatih Poyraz
Hayri Alıcı
Umit Yuksek
Abdullah Orhan Demirtas
Murat Sucu
Publikationsdatum: 14.08.2019
Verlag: Springer Medizin
Erschienen in: Herz / Ausgabe 1/2021
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-019-04842-w

Neu im Fachgebiet Kardiologie

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

ESC-Leitlinie 2020 zur Behandlung von Erwachsenen mit angeborenem Herzfehler (ACHD)

Evaluation of the relationship between COVID-19 pneumonia severity and pulmonary artery diameter measurement

Transvenous extraction of pacemaker leads via femoral approach using a gooseneck snare

Case-control study on the association between the GATA2 gene and premature myocardial infarction in the Iranian population